All filters
E-Posters
TDF Surveillance And Clinically Relevant Resistance In Spain: 2019 Update
F. GarcÃa
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HCV Resistance Associated Variants Following Directly Acting Agent Therapy Failure- Real Life Data From Poland
M. Parczewski
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence Of Transmitted Resistance Mutations To Rilpivirine And Doravirine In Treatment-Naive Patients In A Large Clinical And Resistance Database
F. Lombardi
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Absence Of GS-6207 Phenotypic Resistance In HIV Gag Cleavage Site Mutants, Patient Isolates With Gag Polymorphisms, And Isolates With Resistance To Existing Drug Classes
N. Margot
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Susceptibility To Bnabs Of Transmitted HIV Variants Among Recent Infections In France
K. Stefic
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Genotyping And Treatment Issues With Unusual 1E And 1G HCV Subtypes From African Subjects: Report Of Two Cases
C. Caudai
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Substantial Clustered Transmission Of The Acute Hepatitis C Among HIV Co-Infected Men-Who-Have-Sex-With-Men (MSM)
D. van de Vijver
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Antiretroviral Resistance In Patients With Multiple Treatment Failure In A Low-Middle Income Setting
J. L. Castillo
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence And Correlates Of Pre-Treatment HIV Drug Resistance Among HIV-Infected In The Republic Of Belarus
E. Gasich
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Late Presentation And HIV Drug Resistance In Patients Followed In Portugal Between 1984-2017
M. Pingarilho
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Prevalence Of Pretreatment HIV-1 Drug Resistance Among Treatment-Naïve Patients In The Russian Federation, 2014–2018
A. Kirichenko
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Genetic Characteristic Of HIV-1 In Patients With Treatment Failure In Kyrgyzstan In 2017-2018
D. Saleeva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
The HBV Treatment Outcome To cART In HBV/HIV Co-Infected Patients Who Failed Lamivudine Containing Regimens
G. Dragovic Lukic
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Feasibility And Efficacy Assessment Of Hepatitis B Vaccination Among Adult Plwh And Vulnerable Population In Vinnytsia Region, Ukraine
T. Melnyk
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Hepatotoxicity And The Hepatic Panel Analysis Among HIV-Positive Ukrainian Patients Receiving Efaverentz And Dolutegravir-Containing Modes
A. Kiurdzhyieva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Natural Course Of Hepatitis C Virus Infection: Which Factors Affect Spontaneous Clearance Of HCV Among The Ukrainian Population?
N. Zhandarova
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Effectiveness And Tolerability Of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/Taf) In HIV-1-Infected Adult Patients In German Routine Clinical Practice – 12-Month Results Of The BICSTaR Cohort
M. Heinzkill
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Long-Acting Cabotegravir + Rilpivirine For HIV Treatment: Flair Week 96 Results
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dual Therapy Including Dolutegravir Plus Boosted-Darunavir Ensures High Rate Of Virological Control And Rare Resistance Selection At Failure In Heavily Treatment Experienced PLWH
D. Armenia
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Real-World Effectiveness Of Elbasvir/Grazoprevir In The Treatment Of Patients With Hepatitis C Virus Genotype 1A Infection In Norway
R. A. Leiva
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Dual Therapy With Dolutegravir Plus Lamivudine In Virologically Suppressed Patients
C. I. Simoes Valente
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV A1 Or B Do Not Differentially Impact Cabotegravir In Vitro Potency Or Durability
J. Jeffrey
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
Molecular Epidemiology Of The HIV-1 Infection In Cyprus (2017-2019): A Polyphyletic Infection With An Increasing Prevalence Of Drug Resistance
L. Kostrikis
Presented at:
European Meeting on HIV & Hepatitis 2020
E-Posters
HIV Evolution In Patients Initiating Antiretroviral Therapy During Primary Infection
B. Abdi
Presented at:
European Meeting on HIV & Hepatitis 2020